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In human leukemia, lineage-specific genes represent
predominant targets of deletion, with lymphoid-spe-
cific genes frequently affected in lymphoid leukemia
and myeloid-specific genes in myeloid leukemia. To
investigate the basis of lineage-specific alterations,
we analyzed global DNA damage in primary B cell
precursors expressing leukemia-inducing onco-
genes by ChIP-seq. We identified more than 1,000
sensitive regions, of which B lineage-specific genes
constitute themost prominent targets. Identified hot-
spots at B lineage genes relate to DNA-DSBs, affect
genes that harbor genomic lesions in human leuke-
mia, and associate with ectopic deletion in success-
fully transformed cells. Furthermore, we show that
most identified regions overlap with gene bodies of
highly expressed genes and that induction of a
myeloid lineage phenotype in transformed B cell pre-
cursors promotes de novo DNA damage at myeloid
loci. Hence, we demonstrate that lineage-specific
transcription predisposes lineage-specific genes in
transformedBcell precursors to DNAdamage, which
is likely to promote the frequent alteration of lineage-
specific genes in human leukemia.INTRODUCTION
Most cancers are genetically unstable (Lengauer et al., 1998)
and exhibit genomic alterations that promote tumor progression
(Vogelstein et al., 2013). Analyses of cancer genomes over the
last decade have revealed highly mutated genomes with more
than 100 alterations per tumor genome for solid tumors (Vogel-
stein et al., 2013), whereas liquid tumors such as leukemia are
less mutated (Mullighan et al., 2007). The analyses of leukemiaCell Rep
This is an open access article undgenomes, however, uncovered that the most prominent group
of genes to become defective in B cell precursor leukemia
(B-cell precursor acute lymphoblastic leukemia [BCP-ALL] or
B-lymphoid acute lymphoblastic leukemia [B-ALL]) are regula-
tors of B cell development (40% in B-ALL and 66%–68% in
high-risk B-ALL (Mullighan et al., 2007, 2009; Zhang et al.,
2011)), with the transcription factors PAX5 and IKZF1 being
altered in32% and29% of cases in high-risk B-ALL, respec-
tively (Mullighan et al., 2009). Deletion of IKZF1 is associated
with particularly poor clinical outcomes (Mullighan et al., 2009),
and recent studies based on a PAX5 restoration model clearly
validated the powerful tumor-suppressive function of PAX5 in
B lineage ALL (Liu et al., 2014). Similar to lymphoidmalignancies,
myeloid-lineage genes are often targets of genomic alteration in
myeloid leukemia (e.g., CEBPA, GATA1, PU.1, and RUNX1;
Rosenbauer and Tenen, 2007). Although this pattern of line-
age-specific genetic lesions in lymphoid and myeloid leukemia
cases has been frequently observed, the mechanistic basis
underlying its appearance remained elusive.
DNA damage resulting from oncogenic stress was proposed
as a cause of genome instability in transformed cells almost 10
years ago (Halazonetis et al., 2008). Malignant transformation
of healthy cells resulting in cancer is frequently associated with
the activation of an oncogene (e.g., BCR-ABL1 in B-ALL), and,
similarly, oncogene activation can occur during tumor progres-
sion. Oncogene activation may cause cellular stress, including
DNA damage, as a result of oxidative stress (Sattler et al.,
2000; Vafa et al., 2002) and/or replicative stress (Di Micco
et al., 2006). The latter has been associated with hyper-replica-
tion, aberrant replication origin firing, and an exhaustion of the
cellular nucleotide pool that interferes with efficient replication
(Bester et al., 2011). DNA damage in oncogene-expressing cells
has been shown to promote malignant transformation and
acquisition of genomic defects in cancer models (Gilad et al.,
2010). Likewise, oncogene-induced DNA damage has been
associated with genomic defects found in human cancer,
including solid tumors (Miron et al., 2015) and B cell lymphoma
(Barlow et al., 2013). However, the potential relevance oforts 18, 1687–1698, February 14, 2017 ª 2017 The Author(s). 1687
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oncogenic stress in promoting genomic defects found in pa-
tients with leukemia remained unclear and has been further
brought into question by the identification of the antibody-diver-
sifying enzymes AID and RAG1 as potential drivers of genomic
defects in ETV6-RUNX1-positive B cell precursor ALL (Swami-
nathan et al., 2015). Likewise, recurrent genomic deletions in
B-ALL have been associated with aberrant RAG1 activity by
others because of the presence of cryptic RAG1 cleavage sites
at individual deletion breakpoints (Holmfeldt et al., 2013; Iaco-
bucci et al., 2009; Mullighan et al., 2008).
To obtain insight into the origin of DNA damage that promotes
genomic defects found in leukemia genomes, here we per-
formed a genome-wide analysis of DNA damage in primary B
cell precursors undergoing oncogene-induced leukemic trans-
formation using chromatin immunoprecipitation sequencing
(ChIP-seq). The cells analyzed by us do not express AID or
RAG1; hence, identified DNA damage is thought to relate pri-
marily to oncogenic stress present in these transformed cells.
RESULTS
Transformed B Cell Precursors Exhibit Genome-wide
DNA Damage
B lymphoid leukemia arises from hematopoietic stem cells or B
cell precursors that acquired a transforming, leukemia-initiating
event. To analyze DNA damage related to leukemic transforma-
tion, we transduced primary murine bone marrow-derived B cell
precursors with retroviral vectors encoding the leukemia-
inducing oncogenes BCR-ABL1 or C-MYC or with an empty
vector (EV) as a control (Figure 1A; Figure S1A). To increase
the sensitivity of DNA damage detection, we used bone marrow
from 53BP1/ mice. As expected, oncogene expression re-
sulted in an immediate response characterized by elevated pro-
liferation and a temporary phase of cellular stress (Figure 1B).
Early-transformed cells further exhibited signs of DNA damage
(Figure 1C; Figure S1B), which was unrelated to apoptosis (Fig-
ure 1D), or expression of AID or RAG1 (Figure S1C). We next
aimed to identify the precise genomic regions that experience
DNA damage upon leukemic transformation. To do so, we per-
formed ChIP-seq on apoptotic/dead cell-depleted fractions us-
ing antibodies for the DNA-bound DNA damage response pro-
tein gH2AX, as done previously by others (Barlow et al., 2013;
Rodriguez et al., 2012; Seo et al., 2012). gH2AX regions were
identified as described previously (Barlow et al., 2013), with mi-
nor modifications to optimize calling of broad gH2AX peaks.
gH2AX signals were highly reproducible in a repeat experiment
(Figures S1D and S1E). In total, 889 and 960 gH2AX-regions
were identified for BCR-ABL1 and C-MYC, respectively (Tables
S1 and S2). Interestingly, gH2AX signal intensities at gH2AX-en-
riched regions were comparable for both BCR-ABL1- and
C-MYC-expressing cells (Figure 1E). This may reflect that
BCR-ABL1- and C-MYC-induced DNA damage arises in a
similar manner (e.g., by replicative stress) or that BCR-ABL1-
induced DNA damage mainly arises from activation of BCR-
ABL1-induced expression of C-MYC (Sawyers, 1993). We there-
fore combined both region lists, yielding a merged list of 1,289
gH2AX sites that were used for further comparison (Table S3).
gH2AX sites were distributed over all chromosomes (Figure 1F),1688 Cell Reports 18, 1687–1698, February 14, 2017but the total coverage across chromosomes highly correlated
with exon coverage per chromosome (Figure 1G).
gH2AX-Marked Genomic Regions Occur at B Cell
Precursor-Specific Genes and Relate to Endogenous
DNA Damage
We next analyzed the identified gH2AX regions for genes that
overlap with them. We observed that many of the most promi-
nent regions affected genes specifically expressed by B cell pre-
cursors (Figure 2A). Furthermore, most of the crucial genes
related to the pre-B cell receptor complex, pre-B cell receptor
signaling, and B cell precursor identity-related transcription
overlappedwith gH2AX-enriched regions present in transformed
B cell precursors (Figure 2B; Figures S2A–S2C). Gene ontology
(GO) pathway analysis of all gH2AX regions confirmed that
they, in many cases, affected immune system-related processes
(Figure S2D; Table S4). To verify that identified gH2AX hotspots
at B lineage genes correlate to sites of active DNA damage, we
next performed DNA fluorescence in situ hybridization (FISH) us-
ing ‘‘break-apart’’ probes for two B lineage gene-related gH2AX
hotspots (BLNK and PAX5) and a gH2AX coldspot (FOXP2) as a
control (Figure 2C). The FISH probes cover the flanking regions
of the target genes and are physically separated when a DNA
double-strand break (DSB) occurs (split signal) (Figure 2C, left).
In agreement with our ChIP-seq results, we could detect a signif-
icant increase in split FISH probe signals for the gH2AX hotspots
in transformed B cell precursors compared with control cells
(Figure 2C, right) but not for the gH2AX-negative region analyzed
as a control. Interestingly, when analyzing a successfully trans-
formed B cell precursor line (>50 days after oncogene induction)
by gH2AX ChIP-seq, we observed that the most prominent
gH2AX region at IGH was diminished (Figure 2D, top). To inves-
tigate whether this may relate to internal deletions at the IGH
locus, we analyzed seven successfully transformed B cell pre-
cursor cell lines for genomic loss at IGH by PCR. We confirmed
genomic loss in two of seven cultures, including the cell line
initially analyzed by ChIP-seq (Figure 2D, bottom). In summary,
our results show that B cell precursor-specific genes represent
prominent gH2AX hotspots in transformed B cell precursors,
that gH2AX enrichment at B lineage genes correlates to endog-
enous DNA damage as validated in a limited number of loci by
DNA-FISH, and that gH2AX-enriched regions can be subject to
genomic deletion during prolonged culture of transformed B
cell precursors.
Identified Regions Locate to Genes Affected by
Genomic Lesions in Human B Cell Precursor Leukemia
Within the most prominent gH2AX regions, we identified B cell
precursor-specific genes but also non-B cell-specific genes
known to become defective in leukemia (e.g., HIST1 and ERG)
(Figure 3A). To evaluate to what extent genomic alterations in hu-
man B-ALL occur at genes that are characterized by gH2AX hot-
spots in transformed B cell precursors, we compared the list of
genes overlapping with gH2AX regions with three datasets doc-
umenting gene defects in human leukemia. Only genomic alter-
ations from these datasets that were present in B cell precursor
leukemia and that related to genomic deletions or translocations
were used for comparison. We found significant enrichment of
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Figure 1. Transformed B Cell Precursors Exhibit Genome-wide DNA Damage
(A) Schematic of the experimental strategy.
(B) Diagram visualizing proliferation (left) and viability (right) of B cell precursor cultures transducedwith the oncogenes BCR-ABL1 or C-MYC or empty vector (EV)
as a control. Shown is one of more than five repeat experiments.
(C)Western blots for the DNA damage-associated phosphorylations gH2AX and p-P53Ser15 in transformed versus untransformed B cell precursors. Shown is one
of more than five repeat experiments.
(D) Left: verification of the dead cell removal procedure by flow cytometry (7-AAD = dead cells, AnnexinV = apoptotic). Right: western blot as in (C) for dead/
apoptotic cell-depleted fractions.
(E) Scatterplot of normalized gH2AX read counts per million reads (nRPM, normalized to input/isotype control library) within gH2AX regions identified for BCR-
ABL1-expressing cells (blue), C-MYC-expressing cells (red), or for both ChIP-seq libraries (common regions = black) (for repeat experiments, see Figures S1D
and S1E). The shaded area indicates regions with gH2AX enrichment above background under both conditions (percent of total regions indicated). Linear
regression (red line) and Pearson’s correlation (p < 2.2 3 1016) were calculated from these common regions.
(F) Chromosomal distribution of gH2AX regions (blue bars) present in transformed B cell precursors. Bar height represents gH2AX signals (RPM of the BCR-ABL1
library) for each region (range = 0–100 RPM).
(G) Comparison of gH2AX region versus exon coverage per chromosome of combined gH2AX regions for BCR-ABL1- and C-MYC-expressing cells. The red line
represents linear regression fit.genes associated with genomic deletions/translocations that
similarly overlapped with gH2AX regions identified by us (Fig-
ure 3B; Table S5). gH2AX regions also located to genomic loci
associated with alterations in B-ALL that were not identified by
the above studies (e.g., BACH2 and MIR142). In total, 27 genes
reported as defective in human B-ALL were present in our
gH2AX region list (Figure S3A) and an additional eight genes
related to B-ALL that displayed gH2AX signals but failed to
pass our stringent region-calling threshold (Figure S3B).gH2AX Hotspots in Transformed B Cell Precursors
Occur at Transcriptionally Active Loci
We next analyzed the genomic location of the identified
regions in more detail. 788 of 1,289 gH2AX regions overlapped
with multiple genes, leading to a total overlap of 1,289 regions
with 2,300 genes. gH2AX regions often specifically covered
the gene body of a respective gene, which was confirmed
by meta-gene analysis (Figure 4A). In agreement with gene
body-associated fragility in transformed B cell precursors,Cell Reports 18, 1687–1698, February 14, 2017 1689
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Figure 2. gH2AX-Marked Genomic Regions Occur at B Cell Precursor-Specific Genes and Relate to Endogenous DNA Damage
(A) Bar diagram of the top-ranked gH2AX regions identified for BCR-ABL1-transformed B cell precursors. Ranking is based on fold change (FC) of the gH2AX
signal compared with control (Iso) signals. Genes that overlap with gH2AX regions are indicated. For multiple regions covering the same gene, regions are
combined, and average FC values are shown (i.e., for HIST1 and HIST2 genes and for LY6E).
(B) Top: representative custom track images for genes with gH2AX regions related to the pre-B cell receptor, pre-BCR signaling, and B cell precursor identity.
Grey boxes indicate gene body location for the indicated genes. Bottom: tables of gH2AX signal FC values and read density per region expressed as reads per
kilobase per million (RPKM) of BCR-ABL1 (B/A) and C-MYCChIP-seq libraries for genes related to respective gene categories. Values shown in gray did not pass
our stringent empirical selection criteria using Statistical Model for Identification of ChIP-Enriched Regions (SICER). Related custom track images can be found in
Figures S2A–S2C.
(C) Verification of DNA damage at gH2AX hotspots at B lineage genes using DNA FISH and break-apart probes. Left: schematic overview of signals detected.
Right: results of five independent experiments for PAX5 and BLNK (gH2AX hotspots) versus FOXP2 (gH2AX coldspot) (data represent mean ± SEM).
(D) Top: custom track visualization of the gH2AXChIP-seq signal at IGH in BCR-ABL1-transformed B cell precursors on day 7 p.i. versus in a BCR-ABL1-induced
B cell precursor cell line (>50 days p.i.). Bottom: analysis of the IGH locus by PCR using genomic DNA as a template. JH4 proximal intronic and Em regions of IGH
were assessed; CD74 was used as a non-IGH control region (one of three repeats is shown). BCR-ABL1-induced cell line #2 is the one analyzed by gH2AX
ChIP-seq above.
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Figure 3. gH2AX Regions Locate to Genes
Affected by Genomic Lesions in Human
B-ALL
(A) Representative custom track images of gH2AX
signals at PAX5, IKZF1, the HIST1H gene cluster,
and ERG for BCR-ABL1 (B/A), C-MYC, and isotype
control (Iso) ChIP-seq libraries. Gene models of
selected genes are highlighted in red and neigh-
boring genes in gray. Grey boxes indicate gene body
location of the indicated gene.
(B) Comparison of genes associated with gH2AX-
enriched regions in transformed B cell precursors
from this study with genes associated with genomic
deletions or translocations in human B-ALL. Com-
parisons were performed against previously pub-
lished datasets on genomic alterations in human
B-ALL, as indicated in the Supplemental Experi-
mental Procedures (Mullighan et al., 2007, 2009;
Roberts et al., 2012). Only genomic defects were
used for comparison that were present in B-ALL,
refer to annotated genes, and are present in
the mouse genome (explained in the Supplemental Experimental Procedures). The overlapping loci indicated refer to genes that overlap with gH2AX regions
identified in BCR-ABL1/C-MYC-transformed murine B cell precursors that were additionally associated with deletions or translocations in human B-ALL
identified by the indicated studies. Statistical analysis was done by two-by-two contingency table analysis as by Swaminathan et al. (2015) and confirmed
significant enrichment of gH2AX region-associated genes with p < 0.0001, p = 0.002, and p = 0.034 for comparisons with the Mullighan et al. (2007, 2009) and
Roberts et al. (2012) datasets, respectively. Custom track images for all overlapping genes can be found in Figure S3.cross-analysis of structural variations (SVs) previously identi-
fied in human leukemia also showed breakpoints to be enriched
within gene bodies (Figure S4A). To assess whether gH2AX re-
gion formation relates to transcription, we next generated ChIP-
seq libraries for the chromatin mark H3K27ac, which is present
at transcriptionally active promoters and enhancers (Shlyueva
et al., 2014). Analysis of H3K27ac distribution confirmed accu-
mulation at transcription start sites (TSSs) in transformed B cell
precursors (Figure S4B). Furthermore, most gH2AX regions ex-
hibited H3K27ac at respective promoters, and abundance of
these two histone marks at overlapping regions showed signif-
icant correlation (Figures 4B and 4C). Analysis by RNA
sequencing (RNA-seq) confirmed gH2AX regions to be en-
riched among highly expressed genes (Figures 4D and 4E)
and that highly expressed genes exhibit greater gH2AX inten-
sities (Figure 4F). Furthermore, genes differentially expressed
between BCR-ABL1 and C-MYC conditions displayed a
concomitant change in gH2AX signal intensity (Figure 4G). In
agreement with increased gH2AX signals at highly transcribed
loci in transformed B cell precursors, we also observed that
induced expression of a transgenic fluorochrome (DS-RED) in
transformed cells resulted in elevated gH2AX accumulation at
the related expression cassette (Figure S4C).
Analysis of Convergent and Divergent Transcription, R
Loop-Forming Sequences, and Early-Replicating Fragile
Sites at gH2AX Regions
To understand the origins of transcription-induced gH2AX re-
gions in transformed B cell precursors, we analyzed whether
gH2AX regions are associated with known causes of transcrip-
tion-related fragility. We first analyzed gH2AX regions for their
relation to convergent and divergent transcription, which have
been associated with genomic instability (Barlow et al., 2013;
Heina¨niemi et al., 2016; Pannunzio and Lieber, 2016). gH2AXregions were enriched at gene pairs compared with isolated
genes but not further enriched for convergent or divergent
gene orientation compared with tandem orientation (Figure 5A,
left). However, in agreement with increased fragility at regions
with convergent and divergent transcription, we observed that
gH2AX signalswere elevated at convergent/divergent gene pairs
compared with tandem genes (Figure 5A, right; p < 1 3 106 for
both, convergent versus tandem and divergent versus tandem
comparisons; Mann-Whitney test). We next assessed whether
gH2AX regions may relate to R loop formation, which can pro-
mote fragility by exposure of single-stranded DNA (ssDNA) or
interference with replication. To do so, we predicted R loop-
forming sequences (RLFSs) for the mouse genome as described
previously (Jenjaroenpun et al., 2015) and analyzed gH2AX re-
gions for enrichment of RLFSs. Of note, RLFSs do not indicate
the actual presence of R-loops but an increased propensity of
a nucleotide sequence to promote R-loop formation. Likewise,
detection of RNA-DNA hybrids by DNA:RNA immunoprecipita-
tion sequencing (DRIP-seq) analysis has shown significant
enrichment of R-loops at computationally predicted RLFSs (Hei-
na¨niemi et al., 2016). We found that genes marked by gH2AX
were enriched for RLFSs compared with the gene population
as a whole (Figure 5B, left) or when considering only highly ex-
pressed genes (Figure 5B, right), suggesting an increased likeli-
hood of R loop formation at gH2AX regions. We next compared
gH2AX regions to locations of early replication fragile sites
(ERFSs) (Barlow et al., 2013), which accumulate DNA DSBs
and gH2AX in response to hydroxyurea (HU)-induced replicative
stress. ERFS hotspots significantly overlapped with the gH2AX
regions identified by us (55% of ERFSs overlapped with 26%
of gH2AX regions) (Figure 5C, left); however, HU-induced
gH2AX signals at ERFSs differed from the signals present in
transformed B cell precursors at overlapping regions (Figure 5C,
right).Cell Reports 18, 1687–1698, February 14, 2017 1691
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Figure 4. gH2AX Hotspots in Transformed B Cell Precursors Relate to Transcriptionally Active Genes
(A) Overlap of gH2AX regions with the indicated gene features for all gH2AX regions identified in transformed B cell precursors. Inset: distribution of gH2AX reads
within gene bodies versus upstream and downstream regions for transformed B cell precursors by meta-gene analysis. Signals are normalized to Iso.
(B) A representative custom track of gH2AX versus H3K27ac read densities.
(C) Scatterplots of gH2AX versus H3K27ac intensities for gH2AX regions. Signals are background-subtracted (‘‘normalized’’) RPM values for gH2AX and
H3K27ac within identified gH2AX regions from the merged gH2AX region list. For better identification of overlapping regions, regions were extended ± 10 kb as
described in the Supplemental Experimental Procedures. Linear regression (red line) and Pearson’s correlation (p < 2.23 1016 for both) between gH2AX versus
H3K27ac signal intensities is shown for regions that contain both gH2AX and H3K27ac signals (gray shaded area, percentage of total indicated). See Figure S4B
for meta-gene analysis of H3K27ac.
(D) Relative gene expression levels ranked by fragments per kilobase of transcript per million reads (FPKM) for BCR-ABL1- and C-MYC-transformed B cell
precursors. Genes overlapping gH2AX-enriched regions are highlighted as indicated.
(E and F) Geneswere categorized as high- or low-expressed relative to themedian expression level across the population of all expressed genes. Inset, left: kernel
density plot of FPKM values; colors indicate expression categories. Relative distribution of gH2AX-enriched genes between expression categories (E) and
distribution of normalized gH2AX values measured for extended gene regions between expression categories (F) are shown. The shaded area indicates kernel
density overlaid with a standard boxplot, and stars indicate the highly significant difference between categories (p < 1 3 1015; Mann-Whitney U test).
(G) Scatterplot of the difference in gH2AX signal (nRPM) across extended gene regions between BCR-ABL1- and C-MYC-transformed B cell precursors.
Differentially expressed genes are highlighted in blue or red as indicated. Linear regression (red line) and Pearson’s rho (r) are indicated.
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Figure 5. Analysis of Convergent and Diver-
gent Transcription, R Loop-Forming Se-
quences, and Early-Replicating Fragile
Sites at gH2AX Regions
(A) Left: gene pairs within 10 kb were categorized
as tandem, convergently, or divergently tran-
scribed, as indicated in the respective diagrams,
or as isolated (no additional gene within 10 kb) or
overlapping. The proportion of genes in each
subset is indicated for both gH2AX region-asso-
ciated genes (left) and the distribution across the
whole genome (right). Right: average fold change
in gH2AX signal in BCR-ABL1 versus isotype
control across gene bodies for each transcription
orientation category, normalized for gene lengths
(p < 1 3 106 for both convergent versus tandem
and divergent versus tandem comparisons using
Mann-Whitney test).
(B) Analysis for the enrichment of predicted RLFSs
at gH2AX-associated genes. The total count of
RLFSs overlapping gH2AX-associated genes
(green line) was compared with the permuted null
distribution of total RLFSs (gray bars) measured by
random sampling of the gene population (the
black line indicates mean, and red indicates a
significance threshold of 0.05). Significant enrich-
ment of RLFSs at gH2AX-associated genes is
observed both among all genes (left) and when
analysis is restricted to only the 1,000 most highly
expressed genes (right).
(C) Left: bar diagram showing the number of
ERFS hotspots (Total) versus the number of these
sites that overlap with gH2AX regions in trans-
formed B cell precursors (Overlapping). The sig-
nificance is indicated by comparison with the
mean permuted number of overlaps from random
re-sampling of equivalently sized regions within
the genome. Right: HU-induced versus BCR-
ABL1-induced gH2AX signal patterns at two
representative loci by custom track visualization.
The bars indicate the ERFS hotspots (mint) and
BCR-ABL1-induced gH2AX regions (red). Grey
boxes indicate gene body location of the high-
lighted gene.Lineage-Specific Transcription Predisposes Lineage-
Specific Genes to DNA Damage
To functionally investigate the potential link between lineage-
specific transcription and DNA damage at lineage-specific
genes, we next investigated whether a fundamental change in
the cell-type-specific transcriptional program of transformed B
cell precursors may cause a concomitant change in DNA dam-
age hotspot localizations at lineage-specific genes. To do so,
we used a similar model as before, in which B cell precursors
are transformed by the BCR-ABL1 oncogene but with the addi-
tion of an inducible CEBPA transgene, which promotes myeloid-
specific transcription and a corresponding myeloid lineage
phenotype in B cell precursors (Chen et al., 2015; Figure 6A).
This allowed us to examine de novo DNA damage-sensitive sites
in transformed B cell precursors by gH2AX ChIP-seq that occuras a consequence of myeloid lineage-specific transcription.
Indeed, induction of amyeloid phenotype (CEBPA + doxycycline
[DOX]) was associated with de novo gH2AX signals at myeloid-
specific genes that were not present in our lymphoid lineage
controls (Figure 6B, bottom; Table S6). gH2AX signals at non-
lineage-specific genes showed no difference between lymphoid
and myeloid phenotypes (Figure 6B, top). gH2AX signals at B
cell-specific genes only showed aminor reduction in CEBPA-ex-
pressing cells compared with controls, possibly reflecting an
incomplete loss of the B cell phenotype in our experiments. To
confirmDNA damage atmyeloid gH2AX hotspots, we performed
DNA FISH as described in Figure 2C but using probes for two
myeloid hotspots (LYZ2 and THBS1). In agreement with our
ChIP-seq results, we detected increased split probe signals for
LYZ2 and THBS1 by DNA FISH in the myeloid compared withCell Reports 18, 1687–1698, February 14, 2017 1693
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Figure 6. Induction of a Myeloid Lineage Phenotype in Transformed B Cell Precursors Causes DNA Damage at Myeloid-Specific Genes
(A) Left: Schematic of the experimental strategy for induction of a myeloid phenotype in transformed B cell precursors using DOX-inducible CEBPA expression.
Right: DOX/CEBPA-mediated induction of themyeloid phenotype verified by flow cytometry using CD11B as amyeloid lineage andCD19 as a B lymphoid lineage
marker. EV-transduced lymphoid leukemia cells were used as a control. Anti-CD11B magnetic bead based cell sorting (MACS) was performed on DOX-treated
cells with inducible CEBPA to reach a purity of >90% CD11B-positive cells for ChIP-seq analysis.
(B) Custom track visualization of gH2AX read densities for non-lineage-specific (HIST1 cluster, top) and myeloid lineage-specific gene loci (LYZ2, bottom). Grey
boxes indicate gene-body location of the indicated gene.
(C) Assessment ofmyeloid gH2AXChIP-seq hotspots identified in CEBPA+DOX cells using DNA FISH and break-apart probes as described in Figure 2C. Results
of five independent experiments for LYZ2 and THBS1 (myeloid gH2AX hotspots) versus FOXP2 (coldspot) are shown (data represent mean ± SEM).
(D) Table of the ten top-ranked genes with significant gH2AX signals specific for CEBPA + DOX cells (by fold change). Full references can be found in the
Supplemental Information.the lymphoid fraction (Figure 6C). Analysis of the top-ranked
gH2AX ChIP-seq regions specific for cells with the myeloid
phenotype further showed that all of them related tomyeloid line-
age or function (Figure 6D). GO pathway analysis additionally
confirmed high enrichment of myeloid-specific genes overlap-1694 Cell Reports 18, 1687–1698, February 14, 2017ping with gH2AX regions identified in cells with the myeloid
phenotype (Table S7). These findings provide a functional valida-
tion of our hypothesis that lineage-specific transcriptional pro-
grams promote fragility of lineage-specific genes in transformed
B cell precursors.
DISCUSSION
Oncogenic lesions in hematopoietic progenitor cells give rise to
B lymphoid and myeloid malignancies that, at the time of diag-
nosis, often carry secondary genomic defects that contribute
to the disease. The most prominent defects in lymphoid leuke-
mia genomes affect lineage-specific genes (Mullighan et al.,
2007, 2009; Zhang et al., 2011) that guide respective hemato-
poietic differentiation and function. Defects at lineage-specific
genes are likely to contribute to the differentiation arrest present
in leukemia cells, which is thought to represent a causative event
for malignant transformation (Rosenbauer and Tenen, 2007). It is
unclear, however, whether defects at lineage-specific genes
arise from random mutation and selection or whether lineage-
specific genes are more likely to become defective. Although
our experiments focus on B cell precursors, our results argue
for the latter. During malignant transformation of B cell precur-
sors by the leukemia-inducing oncogenes C-MYC and BCR-
ABL1, B lineage-specific genes become prominent gH2AX
hotspots that relate to DNA DSBs, as shown by DNA FISH for
PAX5 and BLNK. gH2AX accumulation is associated with
increased transcription, and induction of myeloid-specific tran-
scription in transformed B cell precursors by CEBPA-mediated
reprogramming further causes de novo gH2AX hotspots at
myeloid-specific genes that relate to DNA DSBs, as shown by
DNA FISH for LYZ2 and THBS1. As we assessed only a relatively
small number of gH2AX hotspots by DNA FISH, further genome-
wide investigation using other tools than ChIP-seq, such as
translocation capture sequencing (TC-seq) (Klein et al., 2011),
DSB-Capture (Lensing et al., 2016), or DSB end sequencing
(END-seq) (Canela et al., 2016) will be beneficial to corroborate
DNA DSBs at all identified gH2AX hotspots. Such analyses
would also allow a more detailed characterization of the precise
breakage sites within identified gH2AX hotspots because gH2AX
spreading can occur over extended distances around a DNA
DSB (e.g., as shown by Bothmer et al., 2011). Nevertheless,
our results show that lineage-specific transcription and the asso-
ciated fragility of highly transcribed loci represents amajor cause
of instability at lineage genes in transformed B cell precursors.
Such predisposition to DNA damage is likely to increase the
occurrence of genomic alterations at B lineage-specific genes
and to facilitate subsequent positive selection during clonal evo-
lution as observed in human B-ALL. Notably, with the two exper-
imental strategies we performed (oncogene induction in primary
B cell precursors and CEBPA-induced reprogramming in BCR-
ABL1-transformed B cell precursors), we analyzed DNA damage
at an early stage of malignant transformation as well as at a late
stage (primary B cell precursors were analyzed 7 days after
oncogene induction [p.i.], whereas CEBPA-reprogrammed cells
were analyzed >30 days p.i.). Because we observed fragility of
lineage-specific genes in both models, our experiments indicate
that this instability phenotype is not limited to the acute response
to oncogene activation but represents a characteristic of both
early- and long-term-transformed cells.
Although our results provide a link between the high frequency
of genomic defects of lineage genes in hematopoietic cancer
and transcription-related DNA damage observed in other exper-
imental contexts, transcription can cause genomic fragility formany reasons. For example, transcription exposes ssDNA,
which is more fragile and vulnerable to DNA damage. ssDNA
can be formed at sites of premature transcription termination
(Wang et al., 2014) or within R-loops that occur naturally during
transcription (Santos-Pereira and Aguilera, 2015; Skourti-Sta-
thaki and Proudfoot, 2014). R-loops have been shown to specif-
ically associate with highly expressed genes in yeast (Chan et al.,
2014), and absence of the DNA damage response protein
BRCA1 has been shown to promote R loop-dependent DNA
damage at transcriptional pause sites (Hatchi et al., 2015). R
loop-associated DNA damage further causes gH2AX accumula-
tion (Hatchi et al., 2015), and RLFSs have been recently
described at structural variation hotspots (Heina¨niemi et al.,
2016). Similarly, we observed that transcription-associated
gH2AX hotspots in transformed B cell precursors are strongly
enriched for RLFSs. Although RLFSs do not indicate the actual
presence of R-loops but an increased likelihood of R loop forma-
tion, RLFSs do have significant predictive power for R-loops
(Heina¨niemi et al., 2016; Jenjaroenpun et al., 2015). However,
RLFSs are abundantly encoded throughout the genome within
and outside of gH2AX regions (Figure S4D), but cell-type-spe-
cific transcription programs are likely to dictate which of these
loci actively form R-loops and, consequently, which genomic re-
gions exhibit fragility. In agreement with this, we showed that
gH2AX hotspot formation and related DNA DSB induction can
be altered by changing lineage-specific transcription.
Additional factors may further amplify transcription-induced
fragility during leukemic transformation, such as divergent and/
or convergent transcription, which, similarly, can lead to expo-
sure of ssDNA and which have been associated with an
increased risk of genomic instability (Barlow et al., 2013; Heina¨-
niemi et al., 2016; Pannunzio and Lieber, 2016). Indeed, we
observed elevated gH2AX signals at convergently and diver-
gently transcribed genes. Alternatively, transcription-related
DNA damage might also occur as a result of Topoisomerase
2 (TOP2)-mediated DNA DSB induction, which has been
described to occur during rapid transcriptional activation of
induced genes (Bunch et al., 2015; Madabhushi et al., 2015).
Notably, gH2AX signals reported for TOP2-induced DNA dam-
age exhibited a gene body-restricted pattern similar to the
pattern present in transformed B cell precursors (Bunch et al.,
2015; Madabhushi et al., 2015). However, we were unable to
assess whether TOP2-related DNA damage may additionally
promote gH2AX hotspot formation and consecutive DNA dam-
age in our experimental model because of immediate induction
of apoptosis in response to TOP2 inhibition (data not shown).
Besides transcription itself, interference between transcription
and replication has been repeatedly reported as a potential
reason for DNA damage (e.g., by Barlow et al., 2013, and Jones
et al., 2013). For example fragile sites, which are especially prone
to DNA damage during replicative stress, often coincide with
sites of high transcription (common fragile sites [CFSs] often
coincide with large and transcriptionally active genes [Helmrich
et al., 2006], andERFSs, similarly, associatewith transcriptionally
active DNA [Barlow et al., 2013]). In agreement with potential
transcription-replication conflicts in transformed B cell precur-
sors, we observed an overlap of 55% of reported ERFS hotspots
(Barlow et al., 2013), with 26% of the gH2AX regions identifiedCell Reports 18, 1687–1698, February 14, 2017 1695
here in transformed B cell precursors. Similarly, a recent report
linked replicative stress in RAS-expressing immortalized fibro-
blasts to transcription-replication conflicts (Kotsantis et al.,
2016). However, RAS-induced transcriptional interference with
replication in fibroblasts related to upregulation of the TATA
box binding protein TBP, but we did not observe any increase
of TBP expression in transformed B cell precursors by RNA-
seq (data not shown). This is in agreement with several studies
by others that showed that oncogenic stress and related DNA
damage can significantly differ between cell types and individual
oncogenes (Maya-Mendoza et al., 2015; Miron et al., 2015).
Nevertheless, we observed that 85% of the gH2AX regions
identified here in transformed B cell precursors overlapped with
early replication domains described for the murine B cell lym-
phoma line CH12 (1,091 of 1,289 regions, p < 13 104; permuta-
tion test) (Stamatoyannopoulos et al., 2012), suggesting interfer-
ence of transcription with replication as a potential cause for
amplification of transcription-induced fragility in transformed B
cell precursors. However, because replication timing is highly
correlated with transcriptional activity in higher eukaryotes
(Sch€ubeler et al., 2002), the relative importance of replication
interference in transformed B cell precursors compared with
the direct effects of transcription alone remains to bedetermined.
EXPERIMENTAL PROCEDURES
Mice
For experiments on early-transformedB cell precursors, 53BP1/mice (Ward
et al., 2003) were used. For experiments involving CEBPA expression (Fig-
ure 6), BCR-ABL1-transformed B cell precursors from wild-type mice were
used. 53BP1/ mice were a kind gift from Dr. Simon Boulton (The Francis
Crick Institute). All experiments were performed in agreement with the Animals
(Scientific Procedures) Act 1986 (ASPA) guidelines and regulations and pro-
tocols approved by the Home Office.
Cell Culture
Bone marrow (BM) was isolated from femora and tibiae of mice and depleted
of erythrocytes using ammonium-chloride-potassium (ACK) lysis buffer
(Gibco). Primary B cell precursors were then enriched and maintained by
ex vivo culture in Iscove’s Modified Dulbecco’s Medium (IMDM) containing
20% fetal calf serum (FCS) (Invitrogen), 1% penicillin/streptomycin (Gibco),
1% L-Glutamine (Gibco), and 50 mM 2-mercaptoethanol (Sigma) at 37C in a
humidified incubator with 5%CO2 in the presence of 10 ng/mL of recombinant
mouse interleukin-7 (IL-7) (PeproTech). DOX-inducible CEBPA and control
cells were those reported by Chen et al. (2015) and were kept in complete
IMDMas described above but without addition of IL-7. Selection of expression
cassettes was maintained using 2 mg/mL Puromycin (Sigma) and 500 mg/mL
Geneticin/G418 (Sigma). CEBPA-mediated reprogramming was induced by
addition of 1 mg/mL DOX (Sigma) for 7 days. Splenic B cells used as controls
for western blot and qRT-PCR were isolated from wild-type mice as described
previously (Feldhahn et al., 2012).
Viral Transduction
Transduction of B cell precursors was performed as described previously
(Feldhahn et al., 2012) but using X-tremeGENE 9 DNA transfection reagent
(Roche) and MIGRI vectors. Empty MIGR1 vector and human BCR-
ABL1P210-MIGR1 were kind gifts from Danilo Perrotti (University of Maryland
School of Medicine). Mouse C-MYC was sub-cloned into MIGR1 from
C-MYC-MIG using XhoI (New England Biolabs). Transduction with MIGRI
vectors was performed by spinoculation on days 2 and 3 after start of the
cell culture. Details on vectors, transduction, and experimental conditions
for experiments involving inducible DS-RED expression can be found in the
Supplemental Experimental Procedures.1696 Cell Reports 18, 1687–1698, February 14, 2017ChIP-Seq, ChIP-qPCR and RNA-Seq
Cells were prepared for ChIP-seq or ChIP-qPCR analysis according to Yamane
et al. (2013)withminormodifications. For each experiment, harvested cells were
depleted of dead/apoptotic cells using the dead cell removal kit (Miltenyi Biotec)
before further processing. ForCEBPAexperiments,myeloid cells were addition-
ally enrichedusing anti-CD11Bmicro-beads (Miltenyi). Primary transformedand
untransformed B cell precursors were typically harvested on day 7 after trans-
duction; for CEBPA experiments, cells were harvested after 7 days of DOX addi-
tion. For library preparation, theNEBNext ChIP-Seq LibraryPrepMasterMix Set
and NEBNext Multiplex Oligos for Illumina (NEB) were used. For RNA-seq, cells
were isolated, cultured, and harvested as for ChIP-seq experiments. RNA was
extracted in duplicate experiments from53 106 cells using theQIAGENRNeasy
mini kit. Libraries were generated from pre-enriched mRNA using the NEBNext
mRNA Library PrepReagent Set for Illumina (NEB) and pre-amplified using the
NEBNextMultiplexOligos for Illumina (NEB). A detailed description of the exper-
imental procedures, bioinformatic analyses, and statistics is available in the
Supplemental Experimental Procedures.
Statistical Analysis
Statistical analysis of DNA FISH and qRT-PCR data was done by paired
Student’s t test ± SEM using GraphPad Prism software. For comparison of
gH2AX regions to published datasets on gene defects in B-ALL, two-by-two
contingency table analysis was performed as by Swaminathan et al. (2015).
For statistical analyses of ChIP-seq and RNA-seq data, please refer to the
Supplemental Experimental Procedures.
DNA FISH
Cultured cells were depleted of dead/apoptotic cells using the dead cell
removal kit (Miltenyi). 2–5 3 106 cells were then cultured in fresh medium
with 100 ng/mL Colcemid (Gibco) for 4 hr and processed as described
previously (Barch et al., 1997). DNA FISH was performed using custom dual-
color break-apart probes (Agilent Technologies) diluted 1:100 in ULTRAhyb
(Ambion) and hybridized overnight. Automated FISH capture and semi-auto-
mated analysis were performed using CytoVision GSL-120 (Leica). Detailed
information on DNA FISH probes will be provided upon request.
qRT-PCR and PCR
For qRT-PCR on IL-7-cultured B cell precursors, cells were typically harvested
on day 7 after transduction, dead/apoptotic cell-depleted, and snap-frozen on
dry ice. For thymus and BM, cells were isolated freshly from 53BP1/ mice
and snap-frozen on dry ice. Stimulated B cells were obtained from the spleen
and cultured as described previously (Feldhahn et al., 2012). RNAwas isolated
as for RNA-seq, and cDNAwas generated using the RevertAid cDNA synthesis
kit (Thermo Fisher Scientific). qPCR was performed using a SYBR green
master mix (Sigma JumpStart) on a StepOnePlus platform (Thermo Fisher
Scientific). Information of primers, PCR conditions, and analysis can be found
in the Supplemental Experimental Procedures. Analysis of the IGH locus for
genomic loss was done as by Jankovic et al. (2013) using the primers and
conditions described.
Flow Cytometry
Survival indicated by forward scatter (FSC)/side scatter (SSC) as well as GFP
or DS-RED expression of transduced cells was assessed by flow cytometry
using FACSCalibur or LSRFortessa (BD Biosciences). For a more detailed
analysis of viability and apoptosis induction, the Annexin V-PE (phycoerythrin)
apoptosis detection kit (BD Biosciences) in combination with 7-AAD (BD Bio-
sciences) was used. For cell surface staining of single-cell suspensions, the
following anti-mouse antibodies were used: CD16/32 (Fc Block, clone
2.4G2, BD Biosciences) and CD19-APC (eBio103), B220-PerCPCy5.5 (RA3-
6B2), IgM-APCe780 (II/41), CD43-PE (eBioR2/60), CD24-FITC (30-F1), and
CD11b-PECy7 (M1/70) (eBioscience).
Western Blot
Protein lysates were made from snap-frozen cell pellets using radioimmuno-
precipitation assay (RIPA) buffer (50 mM Tris-HCl [pH 8.0], 0.5 mM EDTA,
0.1% SDS, 1% NP-40/IGEPAL (octylphenoxypolyethoxyethanol), 0.5% so-
dium deoxycholate, and 150 mM NaCl). 10–20 mg of proteins were analyzed
by SDS-PAGE gel electrophoresis and western blot using the Mini-PROTEAN
blotting module and Tris-Glycine eXtended (TGX) stain-free pre-cast gels (Bio-
Rad). For detection of specific proteins, the following antibodies were used:
anti-phospho-histone H2A.X (serine 139, gH2AX) clone JBW301 (Millipore),
anti-phospho-P53 (serine 15, Cell Signaling Technology), anti-a-tubulin (Ab-
cam), anti-LAMIN B1 (Abcam), and anti-AID (L7E7) (Cell Signal).ACCESSION NUMBERS
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